rs61733388

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007214.5(SEC63):​c.2027C>T​(p.Thr676Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0216 in 1,577,850 control chromosomes in the GnomAD database, including 454 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 27 hom., cov: 30)
Exomes 𝑓: 0.022 ( 427 hom. )

Consequence

SEC63
NM_007214.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.20
Variant links:
Genes affected
SEC63 (HGNC:21082): (SEC63 homolog, protein translocation regulator) The Sec61 complex is the central component of the protein translocation apparatus of the endoplasmic reticulum (ER) membrane. The protein encoded by this gene and SEC62 protein are found to be associated with ribosome-free SEC61 complex. It is speculated that Sec61-Sec62-Sec63 may perform post-translational protein translocation into the ER. The Sec61-Sec62-Sec63 complex might also perform the backward transport of ER proteins that are subject to the ubiquitin-proteasome-dependent degradation pathway. The encoded protein is an integral membrane protein located in the rough ER. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006633669).
BP6
Variant 6-107876571-G-A is Benign according to our data. Variant chr6-107876571-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 260153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-107876571-G-A is described in Lovd as [Benign]. Variant chr6-107876571-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0172 (2527/147314) while in subpopulation NFE AF= 0.0271 (1827/67524). AF 95% confidence interval is 0.026. There are 27 homozygotes in gnomad4. There are 1146 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2527 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SEC63NM_007214.5 linkuse as main transcriptc.2027C>T p.Thr676Ile missense_variant 19/21 ENST00000369002.9 NP_009145.1
SEC63XM_047418130.1 linkuse as main transcriptc.1859C>T p.Thr620Ile missense_variant 19/21 XP_047274086.1
SEC63XM_047418131.1 linkuse as main transcriptc.1607C>T p.Thr536Ile missense_variant 18/20 XP_047274087.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SEC63ENST00000369002.9 linkuse as main transcriptc.2027C>T p.Thr676Ile missense_variant 19/211 NM_007214.5 ENSP00000357998 P1
SEC63ENST00000459782.1 linkuse as main transcriptn.830C>T non_coding_transcript_exon_variant 1/31
SEC63ENST00000473746.1 linkuse as main transcriptn.674C>T non_coding_transcript_exon_variant 3/42

Frequencies

GnomAD3 genomes
AF:
0.0172
AC:
2529
AN:
147240
Hom.:
27
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00489
Gnomad AMI
AF:
0.0396
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.0214
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00322
Gnomad FIN
AF:
0.0172
Gnomad MID
AF:
0.0272
Gnomad NFE
AF:
0.0271
Gnomad OTH
AF:
0.0186
GnomAD3 exomes
AF:
0.0174
AC:
4368
AN:
250980
Hom.:
47
AF XY:
0.0177
AC XY:
2406
AN XY:
135666
show subpopulations
Gnomad AFR exome
AF:
0.00394
Gnomad AMR exome
AF:
0.0115
Gnomad ASJ exome
AF:
0.0260
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00291
Gnomad FIN exome
AF:
0.0186
Gnomad NFE exome
AF:
0.0268
Gnomad OTH exome
AF:
0.0193
GnomAD4 exome
AF:
0.0220
AC:
31515
AN:
1430536
Hom.:
427
Cov.:
28
AF XY:
0.0216
AC XY:
15422
AN XY:
713366
show subpopulations
Gnomad4 AFR exome
AF:
0.00397
Gnomad4 AMR exome
AF:
0.0115
Gnomad4 ASJ exome
AF:
0.0288
Gnomad4 EAS exome
AF:
0.0000512
Gnomad4 SAS exome
AF:
0.00282
Gnomad4 FIN exome
AF:
0.0192
Gnomad4 NFE exome
AF:
0.0255
Gnomad4 OTH exome
AF:
0.0188
GnomAD4 genome
AF:
0.0172
AC:
2527
AN:
147314
Hom.:
27
Cov.:
30
AF XY:
0.0161
AC XY:
1146
AN XY:
71360
show subpopulations
Gnomad4 AFR
AF:
0.00488
Gnomad4 AMR
AF:
0.0121
Gnomad4 ASJ
AF:
0.0214
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00323
Gnomad4 FIN
AF:
0.0172
Gnomad4 NFE
AF:
0.0271
Gnomad4 OTH
AF:
0.0185
Alfa
AF:
0.0247
Hom.:
93
Bravo
AF:
0.0161
TwinsUK
AF:
0.0218
AC:
81
ALSPAC
AF:
0.0241
AC:
93
ESP6500AA
AF:
0.00363
AC:
16
ESP6500EA
AF:
0.0267
AC:
230
ExAC
AF:
0.0178
AC:
2166
Asia WGS
AF:
0.00289
AC:
10
AN:
3476
EpiCase
AF:
0.0266
EpiControl
AF:
0.0286

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 16, 2020- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Polycystic liver disease 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.064
T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.29
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0066
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
0.71
N
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.13
Sift
Benign
0.20
T
Sift4G
Benign
0.15
T
Polyphen
0.10
B
Vest4
0.089
MPC
0.34
ClinPred
0.012
T
GERP RS
1.6
Varity_R
0.026
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61733388; hg19: chr6-108197775; COSMIC: COSV64602823; COSMIC: COSV64602823; API